- Home
- MRBK vs PALI Comparison
MRBK vs PALI Comparison
Compare MRBK & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRBK | PALI |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.1M | 240.2M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MRBK | PALI |
|---|---|---|
| Price | $18.97 | $1.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $20.00 | $13.00 |
| AVG Volume (30 Days) | 70.1K | ★ 2.8M |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | ★ 25.00 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $5,735,000.00 | $260,000.00 |
| Revenue This Year | $25.40 | N/A |
| Revenue Next Year | $8.15 | N/A |
| P/E Ratio | $14.73 | ★ N/A |
| Revenue Growth | 16.38 | ★ 1500.39 |
| 52 Week Low | $11.17 | $0.55 |
| 52 Week High | $21.03 | $2.64 |
Technical Indicators
Market Signals| Indicator | MRBK | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 43.28 | 57.27 |
| Support Level | $14.00 | $1.57 |
| Resistance Level | $19.24 | $1.93 |
| Average True Range (ATR) | 0.61 | 0.12 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 31.54 | 86.79 |
Price Performance
Historical ComparisonAbout MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.